Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors.
Kaieda, A., Takahashi, M., Takai, T., Goto, M., Miyazaki, T., Hori, Y., Unno, S., Kawamoto, T., Tanaka, T., Itono, S., Takagi, T., Hamada, T., Shirasaki, M., Okada, K., Snell, G., Bragstad, K., Sang, B.C., Uchikawa, O., Miwatashi, S.(2018) Bioorg Med Chem 26: 647-660
- PubMed: 29291937 
- DOI: 10.1016/j.bmc.2017.12.031
- Primary Citation of Related Structures:  
5WJJ, 6ANL - PubMed Abstract: 
We identified novel potent inhibitors of p38 MAP kinase using structure-based design strategy. X-ray crystallography showed that when p38 MAP kinase is complexed with TAK-715 (1) in a co-crystal structure, Phe169 adopts two conformations, where one interacts with 1 and the other shows no interaction with 1 ...